Nomura Holdings’s Zevra Therapeutics ZVRA Stock Holding History

Nomura Holdings’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-733	Closed	-$170K	–	1672
2016 Q1	$170K	Buy	+733	New	+$178K	﹤0.01%	1282

Other funds holding ZVRA

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Nomura Holdings's ZVRA Position: Q2 2016 in Review

Nomura Holdings sold out of Zevra Therapeutics (ZVRA) in Q2 2016, closing a stake of 733 shares — an estimated $170K sold.

Nomura Holdings first reported a position in ZVRA in Q1 2016 and held it in 1 quarter. The position peaked at $170K in Q1 2016. 40 funds tracked by Wall St. Rank hold ZVRA as of Q2 2016.

Nomura Holdings reported no remaining Zevra Therapeutics position as of Q2 2016 after selling out during the quarter.
Nomura Holdings sold 733 Zevra Therapeutics shares in Q2 2016, an estimated $170K.
Nomura Holdings first reported a position in Zevra Therapeutics in Q1 2016 and held it in 1 quarter.
Nomura Holdings's Zevra Therapeutics position peaked at $170K in Q1 2016.
40 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.